Immuneering Corp (IMRX)
1.98
+0.12
(+6.45%)
USD |
NASDAQ |
Nov 05, 16:00
1.98
0.00 (0.00%)
After-Hours: 19:14
Immuneering Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.0005M |
| September 30, 2022 | 0.0384M |
| June 30, 2022 | 0.0944M |
| March 31, 2022 | 0.1837M |
| December 31, 2021 | 0.1896M |
| September 30, 2021 | 0.4821M |
| Date | Value |
|---|---|
| June 30, 2021 | 0.66M |
| March 31, 2021 | 0.7482M |
| December 31, 2020 | 0.6651M |
| September 30, 2020 | 0.6826M |
| June 30, 2020 | 0.4808M |
| March 31, 2020 | 0.483M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0005M
Minimum
Dec 2022
0.7482M
Maximum
Mar 2021
0.3924M
Average
0.4815M
Median
Revenue (Quarterly) Benchmarks
| Singular Genomics Systems Inc | 0.737M |
| Biomarin Pharmaceutical Inc | 745.74M |
| Integra Lifesciences Holdings Corp | 418.18M |
| Eton Pharmaceuticals Inc | 9.074M |
| Tenon Medical Inc | 0.901M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.08M |
| Total Expenses (Quarterly) | 14.91M |
| EPS Diluted (Quarterly) | -0.47 |
| Enterprise Value | -4.573M |
| Earnings Yield | -96.46% |
| Normalized Earnings Yield | -96.97 |